Sintx Technologies Inc (SINT)

$2.52 -0.02 (-0.79%)
Market Cap 10.39M
Revenue (ttm) 1.02M
Net Income (ttm) -10.36M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,015.69%
Debt to Equity Ratio 0.00
Volume 7,900
Avg Vol 32,880
Day's Range N/A - N/A
Shares Out 4.12M
Stochastic %K 73%
Beta 0.66
Analysts Sell
Price Target $16.00

Company Profile

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (P...

Industry: Medical Devices
Sector: Healthcare
Phone: 801 839 3500
Address:
1885 West 2100 South, Salt Lake City, United States
Makingmillions192
Makingmillions192 Apr. 3 at 10:28 PM
$LEXX $SINT Keep singing the same old tune, Boston. No one’s buying it. You’re claiming Bunka is 'front-running' by gifting shares to adjust his cost basis? That’s legally impossible. The Supreme Court settled this in Commissioner v. Fink. They ruled that surrendering shares is a 'capital contribution,' not a deductible loss. It doesn't give him a tax shield or a 'get out of jail free' card for his remaining position. In fact, he loses money today to benefit the company’s structure. Why would a Chairman commit financial suicide by giving away $100K+ in equity if he thought a crash was coming? He wouldn’t. He’d be dumping into the bid. Gifting to the treasury is a 'Cap Table Cleanup' to grease the wheels for a buyer. Period. 🤡 I have this clown LOSTON blocked and he’s still signing this manipulation crap. That short position must be hurting 🥵
0 · Reply
SnoopyDog
SnoopyDog Apr. 3 at 8:00 PM
$SINT $LEXX what do we see here
1 · Reply
Boston7452
Boston7452 Apr. 3 at 5:46 PM
$SINT $LEXX @Makingmillions192 This cost basis is the result of illegal manipulation to cost basis harvest via convertibles and reverse splits MM. Something I believe Lexx may see. "Boston has never owned this stock other for than the purpose of covering his short position. Boston is a serial shorter"
3 · Reply
Makingmillions192
Makingmillions192 Apr. 2 at 8:29 PM
$SINT Boston has never owned this stock other for than the purpose of covering his short position. Boston is a serial shorter
0 · Reply
Boston7452
Boston7452 Apr. 2 at 8:20 PM
$SINT I may not have any faith in mgmt, but I do in the IP.
0 · Reply
SnoopyDog
SnoopyDog Apr. 2 at 8:14 PM
$SINT impressive you still buying
0 · Reply
Boston7452
Boston7452 Apr. 2 at 1:09 AM
$SINT have to wonder how many shares are remaining. i couldn't get a 1k order filled.
0 · Reply
SnoopyDog
SnoopyDog Mar. 31 at 9:48 AM
$SINT USD 2.21 per Share
0 · Reply
OwlKing
OwlKing Mar. 31 at 3:18 AM
$SINT patent value?
0 · Reply
Boston7452
Boston7452 Mar. 30 at 3:27 PM
$SINT No real volume Snoop. This looks like whats going on...something Anson family of funds do between each other all the time. ”Creating False Selling Pressure: The manipulator simultaneously buys and sells the same asset to themselves (or between controlled accounts) at increasingly lower prices.”
0 · Reply
Latest News on SINT
SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

Mar 23, 2026, 9:15 AM EDT - 13 days ago

SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

Mar 19, 2026, 7:30 AM EDT - 17 days ago

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

Feb 18, 2026, 8:30 AM EST - 6 weeks ago

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5

Jan 29, 2026, 9:00 AM EST - 2 months ago

SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

Dec 1, 2025, 8:30 AM EST - 4 months ago

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

Nov 3, 2025, 8:00 AM EST - 5 months ago

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

Oct 20, 2025, 7:00 AM EDT - 5 months ago

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

Oct 14, 2025, 7:00 AM EDT - 6 months ago

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

Sep 8, 2025, 7:54 AM EDT - 7 months ago

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

Sep 8, 2025, 7:00 AM EDT - 7 months ago

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

Aug 15, 2025, 7:00 AM EDT - 8 months ago

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

Aug 4, 2025, 7:00 AM EDT - 8 months ago

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

Jun 24, 2025, 8:30 AM EDT - 10 months ago

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

May 22, 2025, 7:00 AM EDT - 11 months ago

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

May 15, 2025, 7:05 AM EDT - 11 months ago

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

Feb 26, 2025, 8:00 AM EST - 1 year ago

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

Feb 20, 2025, 6:15 AM EST - 1 year ago

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Feb 19, 2025, 6:00 AM EST - 1 year ago

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

Nov 21, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

Nov 19, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

SINTX Technologies Announces Stock Repurchase Program

Nov 18, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Announces Stock Repurchase Program

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

Nov 14, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Oct 1, 2024, 8:00 AM EDT - 1 year ago

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

Sep 20, 2024, 8:00 AM EDT - 1 year ago

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Sep 9, 2024, 8:00 AM EDT - 1 year ago

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

SINTX Technologies to Explore Strategic Opportunities

Jun 18, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies to Explore Strategic Opportunities

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

Jun 12, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

Jun 6, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

May 23, 2024, 9:00 AM EDT - 2 years ago

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

Apr 29, 2024, 9:14 AM EDT - 2 years ago

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

Apr 3, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

SINTX Technologies Announces Proposed Public Offering of Common Stock

Mar 29, 2024, 4:00 PM EDT - 2 years ago

SINTX Technologies Announces Proposed Public Offering of Common Stock

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

Mar 25, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)

Feb 23, 2024, 7:50 AM EST - 2 years ago

Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)

GRI

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

Feb 21, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

SINTX Technologies Announces Closing of $4.0 Million Public Offering

Feb 2, 2024, 2:33 PM EST - 2 years ago

SINTX Technologies Announces Closing of $4.0 Million Public Offering

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

Jan 31, 2024, 9:20 AM EST - 2 years ago

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

Jan 30, 2024, 4:01 PM EST - 2 years ago

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

Jan 23, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

Jan 4, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Nov 7, 2023, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

Nov 3, 2023, 8:28 AM EDT - 2 years ago

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

ARQT HSCS

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

Oct 11, 2023, 9:00 AM EDT - 2 years ago

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

Aug 17, 2023, 9:00 AM EDT - 2 years ago

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

SINTX Technologies Announces Closing of $12.0 Million Public Offering

Feb 10, 2023, 1:52 PM EST - 3 years ago

SINTX Technologies Announces Closing of $12.0 Million Public Offering

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

Feb 7, 2023, 9:05 PM EST - 3 years ago

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

Jan 19, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

SINTX TECHNOLOGIES REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT

Jan 6, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT

Makingmillions192
Makingmillions192 Apr. 3 at 10:28 PM
$LEXX $SINT Keep singing the same old tune, Boston. No one’s buying it. You’re claiming Bunka is 'front-running' by gifting shares to adjust his cost basis? That’s legally impossible. The Supreme Court settled this in Commissioner v. Fink. They ruled that surrendering shares is a 'capital contribution,' not a deductible loss. It doesn't give him a tax shield or a 'get out of jail free' card for his remaining position. In fact, he loses money today to benefit the company’s structure. Why would a Chairman commit financial suicide by giving away $100K+ in equity if he thought a crash was coming? He wouldn’t. He’d be dumping into the bid. Gifting to the treasury is a 'Cap Table Cleanup' to grease the wheels for a buyer. Period. 🤡 I have this clown LOSTON blocked and he’s still signing this manipulation crap. That short position must be hurting 🥵
0 · Reply
SnoopyDog
SnoopyDog Apr. 3 at 8:00 PM
$SINT $LEXX what do we see here
1 · Reply
Boston7452
Boston7452 Apr. 3 at 5:46 PM
$SINT $LEXX @Makingmillions192 This cost basis is the result of illegal manipulation to cost basis harvest via convertibles and reverse splits MM. Something I believe Lexx may see. "Boston has never owned this stock other for than the purpose of covering his short position. Boston is a serial shorter"
3 · Reply
Makingmillions192
Makingmillions192 Apr. 2 at 8:29 PM
$SINT Boston has never owned this stock other for than the purpose of covering his short position. Boston is a serial shorter
0 · Reply
Boston7452
Boston7452 Apr. 2 at 8:20 PM
$SINT I may not have any faith in mgmt, but I do in the IP.
0 · Reply
SnoopyDog
SnoopyDog Apr. 2 at 8:14 PM
$SINT impressive you still buying
0 · Reply
Boston7452
Boston7452 Apr. 2 at 1:09 AM
$SINT have to wonder how many shares are remaining. i couldn't get a 1k order filled.
0 · Reply
SnoopyDog
SnoopyDog Mar. 31 at 9:48 AM
$SINT USD 2.21 per Share
0 · Reply
OwlKing
OwlKing Mar. 31 at 3:18 AM
$SINT patent value?
0 · Reply
Boston7452
Boston7452 Mar. 30 at 3:27 PM
$SINT No real volume Snoop. This looks like whats going on...something Anson family of funds do between each other all the time. ”Creating False Selling Pressure: The manipulator simultaneously buys and sells the same asset to themselves (or between controlled accounts) at increasingly lower prices.”
0 · Reply
SnoopyDog
SnoopyDog Mar. 30 at 3:14 PM
$SINT bid 2.19
0 · Reply
Makingmillions192
Makingmillions192 Mar. 29 at 11:02 PM
$SINT 🚨 GENERAL WARNING 🚨 A frequent user here @Boston7452 has been exposed as running a sophisticated short selling campaign on stocks. This user is deploying a "Short and Distort" campaign—using technical jargon to manufacture FUD (Fear, Uncertainty, Doubt) and trigger panic-selling. The Manipulation Playbook: • The Survival Scare: Frames bullish "cap table" cleanups (exit prep) as bearish "reverse split" signals to hit stop-losses. • Warrant Math Fraud: Claims a split "increases" warrant value. Reality: Price and quantity adjust proportionally; value remains neutral. • Legal Spin: Misquotes tax rulings (like Comm. v. Fink) to frame personal financial sacrifices as "loopholes." He often seems like a bullish member of the community but the reality is that he only does so to gain credibility. Once accomplished he uses false pretences and misinformation to cast doubt.
1 · Reply
OwlKing
OwlKing Mar. 29 at 6:58 PM
$SINT $TIRX Value good
0 · Reply
Makingmillions192
Makingmillions192 Mar. 29 at 6:54 PM
$LEXX More likely that a deal in fact does happen in the next 30 days. The short tactics and fear mongering doesn’t work on me pal. Anyone who starts talking about a reverse split always shows their true intentions and as I highlighted for the community already, you are a serial shorter. Anyone who looks at your history with $SINT can clearly see that. Sorry pal good try though
1 · Reply
Boston7452
Boston7452 Mar. 27 at 9:26 PM
$SINT Si3N4 could be our main line of defense: A room full of flu patients and no one got sick A bold flu experiment shows that good airflow, fewer coughs, and the right protection can stop the virus cold—even indoors. ”The results highlight ventilation, air movement, and masks as key defenses against infection.”
2 · Reply
TradeWithCreed
TradeWithCreed Mar. 27 at 8:47 PM
$INDO $SINT $KXIN $TIRX chi
0 · Reply
Boston7452
Boston7452 Mar. 27 at 7:36 PM
$SINT There is another pandemic coming and it could come as early as late 2027/early 2028. Sintx has a solution if only they would actually try to commercialize the masks, filters (including air filtration), and other PPE!
0 · Reply
SnoopyDog
SnoopyDog Mar. 27 at 7:19 AM
$SINT this all doesent matter. The lower the price the more painful will be next offering. All the consequence of years of miscommunication and misleading the market.
1 · Reply
Boston7452
Boston7452 Mar. 26 at 10:46 PM
$SINT This looks like whats going on: ”Creating False Selling Pressure: The manipulator simultaneously buys and sells the same asset to themselves (or between controlled accounts) at increasingly lower prices.”
0 · Reply
Boston7452
Boston7452 Mar. 26 at 8:41 PM
Is most of $SINT shares in hands of only a few? Is that why so little volume moves the stock?
0 · Reply
Boston7452
Boston7452 Mar. 26 at 6:27 PM
$SINT You do realize that theres like no volume in the move right? 14k is all.
1 · Reply
SnoopyDog
SnoopyDog Mar. 26 at 6:09 PM
$SINT yes here we go, every day thousands of dollars are burned for high salaries while no revenue coming in. Cash lasts a few month only, maybe even weeks only.
0 · Reply